31 min listen
Why Do I Need Adjuvant Therapy? Communicating the Risks for HR-Positive, HER2-Negative EBC at High Risk of Recurrence
Why Do I Need Adjuvant Therapy? Communicating the Risks for HR-Positive, HER2-Negative EBC at High Risk of Recurrence
ratings:
Length:
18 minutes
Released:
Dec 18, 2023
Format:
Podcast episode
Description
Your patient has endured surgery, radiation therapy, and chemotherapy. After all that, how do you discuss the risk of recurrence and additional treatment? Credit available for this activity expires: 12/15/2024 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/999193?ecd=bdc_podcast_libsyn_mscpedu
Released:
Dec 18, 2023
Format:
Podcast episode
Titles in the series (100)
Multiparametric MRI for Active Surveillance of Prostate Cancer: How are you managing your prostate cancer patients on active surveillance? Credit available for this activity expires: 5/25/24 Earn Credit / Learning Objectives & Disclosures: by Keeping Current CME